Colgate-Palmolive, US1941621039

Colgate-Palmolive stock: JPMorgan raises target to USD 104, slightly lower pre-market

Published on 10/20/2026 at 08:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
JPMorgan kept its overweight rating on October 19, 2026. At Lang & Schwarz the stock trades pre-market at EUR 82.70 on October 20, 2026, 0.46 percent below the Xetra close of October 19, 2026.

JPMorgan changes its target

  • JPMorgan raised its Colgate-Palmolive target to USD 104 on October 19, 2026.
  • The bank maintained an overweight rating on October 19, 2026.
  • Colgate-Palmolive stock trades pre-market at EUR 82.70 at 8:18 a.m. CEST at Lang & Schwarz on October 20, 2026, 0.46 percent below the Xetra close of October 19, 2026.
Colgate-Palmolive Hauptquartier US1941621039 als moderner Glasturm mit Spiegelteich im fotorealistischen CGI-Architektur-Render dargestellt, Illustration mit AI erstellt.

On October 19, 2026, MarketBeat reported that JPMorgan raised its Colgate-Palmolive price target to USD 104 from USD 103 and maintained an overweight rating. Colgate-Palmolive stock trades pre-market at EUR 82.70 at 8:18 a.m. CEST at Lang & Schwarz on October 20, 2026, 0.46 percent below the Xetra close of October 19, 2026 (EUR 83.08).

JPMorgan target raised

MarketBeat said the JPMorgan research note was issued on Monday, October 19, 2026. The report described the brokerage's rating as overweight.

Ahead of the Xetra open

The pre-market indication is EUR 0.38 below the Xetra close. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Colgate-Palmolive stock.

Business and market context

Colgate-Palmolive earns revenue by selling consumer products in oral care, pet nutrition, home care and personal care markets. Market context: Market report S&P 500.

More news and analysis on Colgate-Palmolive stock

Disclaimer...
en | US1941621039 | COLGATE-PALMOLIVE | boerse | 70369326 | bgmi